A Mohar

Summary

Country: Mexico

Publications

  1. ncbi Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial
    V A Ramirez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Department of Health Care, Villa Quietud, Consejo Nacional para la prevencion y control del SIDA, Toriello Guerra, Mexico
    Clin Infect Dis 28:892-4. 1999
  2. ncbi Frequency of oral conditions in a dermatology clinic
    V A Ramirez-Amador
    Department of Health Care, Universidad Autonoma Metropolitana Xochimilco, Consejo Nacional para la prevencion y control del SIDA, Mexico City, Mexico
    Int J Dermatol 39:501-5. 2000
  3. ncbi The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico
    Velia Ramírez-Amador
    Universidad Autónoma Metroploitana Xochimilco, Mexico City, Mexico
    Medicine (Baltimore) 82:39-50. 2003
  4. ncbi Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial
    V Ramirez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Calzada del Hueso 1100, 04960 Mexico City, Mexico
    Oral Oncol 38:460-7. 2002
  5. ncbi [Association of oral lesions with HIV serological status]
    Velia Ramírez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Mexico, D F, Mexico
    Salud Publica Mex 44:87-91. 2002
  6. ncbi High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus
    P Volkow
    Division of Research, UNAM, Mexico City, Mexico
    Gynecol Oncol 82:27-31. 2001
  7. ncbi Surgical site infections at the National Cancer Institute in Mexico: a case-control study
    D Vilar Compte
    Department of Infectious Diseases and the Clinical Research Investigation Division, , Mexico, D F 14000, Mexico
    Am J Infect Control 28:14-20. 2000
  8. ncbi Epstein-Barr virus-associated gastric carcinoma in Mexico: analysis of 135 consecutive gastrectomies in two hospitals
    R Herrera-Goepfert
    Department of Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Mod Pathol 12:873-8. 1999
  9. ncbi Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma
    N A Hernandez-Rodriguez
    División of Investigación Clínica, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Cancer Detect Prev 25:210-5. 2001
  10. ncbi p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease
    L Quintanilla-Martinez
    Institute of Pathology, GSF National Research Center for Environment and Health, Neuherberg, Germany
    Am J Pathol 159:2095-105. 2001

Collaborators

  • P Volkow
  • F Lozada-Nur
  • G Reyes-Teran
  • Juan Sierra-Madero
  • Velia Ramírez Amador
  • Velia Ramírez-Amador
  • V A Ramirez-Amador
  • R Herrera-Goepfert
  • L Esquivel-Pedraza
  • L Chihu
  • Gabriela Anaya-Saavedra
  • Imelda González-Ramírez
  • Lilly Esquivel-Pedraza
  • V Ramirez-Amador
  • L Quintanilla-Martinez
  • N A Hernandez-Rodriguez
  • D Vilar Compte
  • J Silva
  • G Ayala
  • G Fierros
  • Sergio Ponce-de-Leon
  • E de la Rosa-García
  • Esther Irigoyen-Camacho
  • L Suchil-Bernal
  • P Volkow-Fernández
  • L Green
  • F Fend
  • R Sotelo
  • G Keller
  • A Gamboa-Dominguez
  • M Nathrath
  • C Gomez-Ruiz
  • E Correa
  • A Meneses
  • A Cabras
  • A Contreras-Paredes
  • H Hoefler
  • L Luna-Contreras
  • M Kremer
  • P Gordillo
  • M De La Rosa
  • R Orozco-Topete
  • S Sandoval
  • M Hernandez-Avila
  • S Ponce-de-Leon
  • S Akiba
  • E Reyes
  • C Fujiyama
  • Y Harada
  • Y Eizuru
  • R Shinkura
  • M Gonzalez-Guevara
  • M Tokunaga

Detail Information

Publications11

  1. ncbi Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial
    V A Ramirez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Department of Health Care, Villa Quietud, Consejo Nacional para la prevencion y control del SIDA, Toriello Guerra, Mexico
    Clin Infect Dis 28:892-4. 1999
    ..Rash was observed in 80% of the thalidomide patients. Although thalidomide demonstrated an unquestionable benefit in treatment of oral ulcers in HIV patients, caution must be taken given the frequent occurrence of side effects...
  2. ncbi Frequency of oral conditions in a dermatology clinic
    V A Ramirez-Amador
    Department of Health Care, Universidad Autonoma Metropolitana Xochimilco, Consejo Nacional para la prevencion y control del SIDA, Mexico City, Mexico
    Int J Dermatol 39:501-5. 2000
    ..Oral mucosal manifestations may be the initial feature, the most florid clinical feature, or the only sign of mucocutaneous diseases...
  3. ncbi The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico
    Velia Ramírez-Amador
    Universidad Autónoma Metroploitana Xochimilco, Mexico City, Mexico
    Medicine (Baltimore) 82:39-50. 2003
    ....
  4. ncbi Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial
    V Ramirez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Calzada del Hueso 1100, 04960 Mexico City, Mexico
    Oral Oncol 38:460-7. 2002
    ..61). Patients in both groups experienced minimal toxicity. We conclude that intralesional vinblastine or STS are adequate for the management of OKS. The benefits of STS are its low cost and ease of use...
  5. ncbi [Association of oral lesions with HIV serological status]
    Velia Ramírez-Amador
    Universidad Autonoma Metropolitana Xochimilco, Mexico, D F, Mexico
    Salud Publica Mex 44:87-91. 2002
    ..To estimate the prevalence of oral lesions and its association with HIV serological status...
  6. ncbi High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus
    P Volkow
    Division of Research, UNAM, Mexico City, Mexico
    Gynecol Oncol 82:27-31. 2001
    ..CONCLUSIONS: We observed a high prevalence of oncogenic HPV types in HIV-positive women. These women should be screened regularly for early diagnosis of premalignant lesions and prevention of cervical cancer...
  7. ncbi Surgical site infections at the National Cancer Institute in Mexico: a case-control study
    D Vilar Compte
    Department of Infectious Diseases and the Clinical Research Investigation Division, , Mexico, D F 14000, Mexico
    Am J Infect Control 28:14-20. 2000
    ..The risk factors associated with surgical site infection are similar to those previously reported. Diabetes mellitus, obesity, and prolonged presence of a surgical drain increased the risk of infection...
  8. ncbi Epstein-Barr virus-associated gastric carcinoma in Mexico: analysis of 135 consecutive gastrectomies in two hospitals
    R Herrera-Goepfert
    Department of Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Mod Pathol 12:873-8. 1999
    ..Environmental factors could influence the distinctive pathologic features of EBV-associated gastric carcinoma in the Mexican population...
  9. ncbi Ki-67: a proliferative marker that may predict pulmonary metastases and mortality of primary osteosarcoma
    N A Hernandez-Rodriguez
    División of Investigación Clínica, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Cancer Detect Prev 25:210-5. 2001
    ..000962). These findings suggest that Ki-67 overexpression could be used as a prognostic molecular marker for the development of PM in osteosarcoma patients...
  10. ncbi p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease
    L Quintanilla-Martinez
    Institute of Pathology, GSF National Research Center for Environment and Health, Neuherberg, Germany
    Am J Pathol 159:2095-105. 2001
    ..The overexpression of p53 and p21, independent of p53 mutations, although as yet not clear, might be the result of Epstein-Barr virus infection, and warrants further investigation...
  11. ncbi Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome
    L Chihu
    National Institute of Public Health, SSA, Cuernavaca, Morelos, Mexico
    J Chemother 17:270-6. 2005
    ..Metronidazole resistance was associated with cagA negative strains with a frequency of 82% (9/11). No significant correlation was found between vacA s/m alleles and metronidazole resistance...